We need value for money from projects of all sizes
Last week, the European Parliament’s budgetary control committee criticised the accounting of several flagship European research projects—including the European Institute of Innovation and Technology, the Innovative Medicines Initiative (IMI) and Iter, the experimental fusion reactor—asking for more detail before approving their budgets.
The rejection was symbolic: the projects aren’t going to be cancelled or curtailed. But it still represents a vote of no confidence in the management of large projects under Horizon 2020.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.